nach oben

International Journal of Clinical Oncology

Erschienen in:

14.06.2016 | Introduction to Invited Review Articles

Biological imaging in clinical oncology—introduction

verfasst von: Yasumasa Nishimura

Erschienen in: International Journal of Clinical Oncology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Excerpt

Advances in various imaging modalities have apparently improved the clinical outcome in oncology. Staging and treatment planning of cancer have mainly been based on computed tomography (CT) and magnetic resonance imaging (MRI). In addition to these anatomical imaging techniques, biological and functional imaging, including positron emission tomography (PET) and functional CT and MRI, have recently advanced. With the addition of PET or PET/CT to CT and MRI, the staging accuracy has improved by detecting nodal and distant metastases [1, 2]. Furthermore, clinical studies using PET/CT for treatment planning have been reported [3‐6]. It has been demonstrated that fused PET/CT images are useful to delineate gross tumor volume (GTV) [2, 3, 7]. …

Rohde M, Dyrvig AK, Johansen J et al (2014) 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis. Eur J Cancer 50:2271–2279CrossRefPubMed

Xu G, Li J, Zuo X et al (2012) Comparison of whole body positron emission tomography (PET)/PET-computed tomography and conventional anatomic imaging for detecting distant malignancies in patients with head and neck cancer: a meta-analysis. Laryngoscope 122:1974–1978CrossRefPubMed

Deantonio L, Beldì D, Gambaro G et al (2008) FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma. Radiat Oncol 18:3–29

Wang D, Schultz CJ, Jursinic PA et al (2006) Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 65:143–151CrossRefPubMed

Schwartz DL, Ford EC, Rajendran J et al (2005) FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation. Head Neck 27:478–487CrossRefPubMed

Vernon MR, Maheshwari M, Schultz CJ et al (2008) Clinical outcomes of patterns receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. Int J Radiat Oncol Biol Phys 70:678–684CrossRefPubMed

Okubo M, Nishimura Y, Nakamatsu K et al (2010) Radiation treatment planning using positoron emission and computed tomography for lung and pharyngeal cancer: a multiple-threshhold method for [18F]fluoro-2-deoxyglucose activity. Int J Radiat Oncol Biol Phys 77:350–356CrossRefPubMed

Pow EH, Kwong DL, McMillan AS et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66:981–991CrossRefPubMed

Kam MK, Leung SF, Zee B et al (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25:4873–4879CrossRefPubMed

10.

Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225–239CrossRefPubMed

11.

Asquith JC, Watts ME, Patel K et al (1974) Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles. Radiat Res 60:108–118CrossRefPubMed

12.

Chapman JD, Baer K, Lee J (1983) Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res 43:1523–1528PubMed

13.

Koh WJ, Rasey JS, Evans ML et al (1991) Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 22:199–212CrossRef

14.

Zimny M, Gagel B, DiMartino E et al (2006) FDG—a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer. Eur J Nucl Med Mol Imaging 33:1426–1431CrossRefPubMed

15.

Tachibana I, Nishimura Y, Shibata T et al (2013) A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy. J Radiat Res 54:1078–1084CrossRefPubMedPubMedCentral

16.

Hoeben BA, Bussink J, Troost EG et al (2013) Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer. Acta Oncol 52:1257–1271CrossRefPubMed

Titel: Biological imaging in clinical oncology—introduction
verfasst von: Yasumasa Nishimura
Publikationsdatum: 14.06.2016
Verlag: Springer Japan
Erschienen in: International Journal of Clinical Oncology / Ausgabe 4/2016
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-016-0999-4

Neu im Fachgebiet Onkologie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Biological imaging in clinical oncology—introduction

Excerpt

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study

Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution

Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors

Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan

Colorectal cancer in young patients: is it a distinct clinical entity?

UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie

UDP-glucuronosyltransferase 1A16 and 28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer